Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc (RNA)
26.66 +0.90 (+3.49%) 04/17/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 26.66 unch (unch) 17:37 ET
Profile for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Avidity Biosciences Inc 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 USA

www.aviditybiosciences.com Employees: 391 P: 858-401-7900

Sector:

Medical

Description:

Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 3,096,661
Enterprise Value, $K 2,876,791
Shares Outstanding, K 120,212
Annual Sales, $ 10,900 K
Annual Net Income, $ -322,300 K
Last Quarter Sales, $ 2,970 K
Last Quarter Net Income, $ -102,260 K
EBIT, $ -378,940 K
EBITDA, $ -397,610 K
60-Month Beta 1.01
% of Insider Shareholders 3.68%
Float, K 115,788
% Float 96.32%
Short Volume Ratio 0.38

Growth:

1-Year Return 13.21%
3-Year Return 54.53%
5-Year Return 0.00%
5-Year Revenue Growth 369.83%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.80 on 02/27/25
Next Earnings Date 05/08/25 [--]
Earnings Per Share ttm -2.89
EPS Growth vs. Prev Qtr -23.08%
EPS Growth vs. Prev Year -1.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.89%
Return-on-Assets % -23.42%
Profit Margin % -2,956.88%
Debt/Equity 0.00
Price/Sales 294.32
Price/Cash Flow N/A
Price/Book 2.23
Book Value/Share 11.94
Interest Coverage -2.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.